Table 1.
Case # | MS type | Myelin status | Disease duration (years) | Age (years) | Sex | EDSS | PMI (h) | Study method |
---|---|---|---|---|---|---|---|---|
MS01 | SPMS | Myelinated/demyelinated | 36 | 45 | M | 7 | 3 | Microarray |
MS02 | SPMS | Demyelinated | 25 | 52 | M | 9.5 | 5 | |
MS03 | PPMS | Myelinated/demyelinated | 9 | 63 | F | 7.5 | 5 | |
MS04 | SPMS | Myelinated | 19 | 53 | F | 9 | 6 | |
MS05 | SPMS | Myelinated/demyelinated | 21 | 53 | F | 8 | 7 | |
MS06 | SPMS | Myelinated/demyelinated | 20 | 60 | F | 8 | 6 | |
MS07 | PPMS | Myelinated/demyelinated | 23 | 75 | M | 9 | 5 | qPCR |
MS08 | SPMS | Myelinated | 26 | 69 | F | 8 | 6 | |
MS09 | SPMS | Demyelinated | 30 | 60 | F | 9 | 8 | |
MS010 | SPMS | Myelinated | 27 | 71 | F | 9.5 | 5 | |
MS011 | SPMS | Myelinated/demyelinated | 35 | 74 | M | 8 | 9 | |
MS012 | SPMS | Demyelinated | 37 | 59 | F | 9 | 5 |
SPMS, secondary‐progressive multiple sclerosis; PPMS, primary‐progressive multiple sclerosis; EDSS, expanded disability status scale; PMI, postmortem interval.